About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Breast Tumour Size Measurement by Field Cycling Imaging

NCT07492043·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Vasiliki Mallikourti, PhD
CONTACT
+44 1224 437831 [email protected]

Lead

University of Aberdeen

With

NHS Grampian

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Females ≥ 18 years old.
Subjects diagnosed with DCIS on initial biopsy.
Lesion size \>1 cm on imaging.
Subjects undergoing surgery as part of their treatment.
Able to fit comfortably in the scanners.
Able to understand written and spoken English.

You may not be if

Subjects undergoing chemotherapy or hormonal therapy.
Individuals unable to give informed consent.
Contra-indications to MRI scanning such as implantable cardiac devices.
Known allergy to contrast agent.

The record

StatusNot yet recruiting

PhaseNo phase

Taking part12

StartedApr 2026

UpdatedMar 25, 2026

Conditions

Breast Cancer Ductal Carcinoma In Situ

Where1

University of Aberdeen
Aberdeen, United Kingdom

Clareo Health | Breast Tumour Size Measurement by Field Cycling Imaging